Reported Reactions

Devices › Device types

FDA product code FBK · class 2 · Gastroenterology, Urology

Endoscopic injection needle, gastroenterology-urology: medical device reports filed with FDA

579 reports carry this product code, 1994–2026; 4 brands with a page.

579
reports with this product code
0% of all MAUDE reports
78
reports, 12 months to August 2026
85 in the 12 months before
87.7%
classified as malfunction
62.3% across all reports
0%
classified as death, as reported
0.9% across all reports

Product code FBK is FDA's classification for "Endoscopic injection needle, gastroenterology-urology" (gastroenterology, Urology panel), a class 2 device. 579 medical device reports carry this product code, 0% of the MAUDE database, from February 1994 to August 2026.

78 reports arrived in the 12 months to August 2026, close to the 85 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (87.7%), injury (10.9%) and other (0.7%). 4 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Single Use Injector367400%95.5%
Interject780.4%99.1%
Single Use Aspiration Needle21440.4%79.4%
Interlink1490%92.1%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Aomori Olympus23139.9%
Cook Endoscopy172.9%
Wilson-Cook Medical91.6%
Olympus Medical Systems71.2%
C R Bard Covington20.3%
Kimberly-Clark10.2%

Reports by month, five years

0918Sep 2021: 7Oct 2021: 0Nov 2021: 1Dec 2021: 102022Jan 2022: 9Feb 2022: 14Mar 2022: 4Apr 2022: 6May 2022: 6Jun 2022: 8Jul 2022: 7Aug 2022: 6Sep 2022: 0Oct 2022: 5Nov 2022: 4Dec 2022: 112023Jan 2023: 13Feb 2023: 6Mar 2023: 6Apr 2023: 4May 2023: 5Jun 2023: 7Jul 2023: 3Aug 2023: 10Sep 2023: 0Oct 2023: 2Nov 2023: 3Dec 2023: 12024Jan 2024: 4Feb 2024: 15Mar 2024: 7Apr 2024: 8May 2024: 5Jun 2024: 18Jul 2024: 6Aug 2024: 2Sep 2024: 4Oct 2024: 3Nov 2024: 5Dec 2024: 172025Jan 2025: 10Feb 2025: 4Mar 2025: 8Apr 2025: 4May 2025: 14Jun 2025: 4Jul 2025: 3Aug 2025: 9Sep 2025: 1Oct 2025: 7Nov 2025: 11Dec 2025: 92026Jan 2026: 3Feb 2026: 11Mar 2026: 0Apr 2026: 9May 2026: 8Jun 2026: 3Jul 2026: 7Aug 2026: 9

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0%0
Injury10.9%63
Malfunction87.7%508
Other0.7%4
Not given0.7%4

Who filed

Manufacturer report92.2%534
Voluntary report4.1%24
User facility report0%0
Distributor report0%0
Not given3.6%21

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Failure to deliverthe device did not deliver the dose or item7913.6%
Breakthe device broke6310.9%
No flow5810%
Infusion or flow problema problem with flow or infusion427.3%
Mechanical problema mechanical problem295%
Activation failure264.5%
Failure to infuse264.5%
Retraction problem244.1%
Detachment of device or device componentpart of the device came off122.1%
Difficult to insertthe device was hard to insert122.1%
Physical resistance/sticking111.9%
Failure to advance101.7%
Obstruction of flow101.7%
Positioning failure101.7%
Complete blockage81.4%
Defective devicethe device was defective81.4%
Device operates differently than expectedthe device behaved unexpectedly81.4%
Failure to discharge81.4%
Failure to eject71.2%
Material twisted/bent71.2%

Questions about endoscopic injection needle, gastroenterology-urology reports

What is product code FBK?

FDA's classification code for "Endoscopic injection needle, gastroenterology-urology", class 2, reviewed by the gastroenterology, Urology panel. Every device report carries the product code of the device involved.

How many reports carry this code?

579 reports through August 2026, 78 of them in the latest 12 months.

Which brands appear most often?

Single Use Injector (367), Interject (7), Single Use Aspiration Needle (2) and Interlink (1). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.